Thereafter, we detected the influence of rTMS administrations on the activities of GSK-3β, Tau, and β-catenin in the brain tissues of mice to provide some information of the treatment mechanism of rTMS on AD. The gene discussed is MAPT; the disease is Alzheimer disease.